國際復材(301526.SZ):境外客戶主要集中於北美、中東、歐洲、南美、東亞等地區
格隆匯2月13日丨國際復材(301526.SZ)在投資者關係表示,公司在海外的巴西、巴林、摩洛哥等地建有玻纖及製品生產基地,在美國、荷蘭、香港等地設立貿易子公司,產品營銷網絡遍佈全球,境外客戶主要集中於北美、中東、歐洲、南美、東亞等地區,均保持與公司長期穩定的合作關係,境外生產經營及業務情況整體相對穩定。當前,全球政治、經濟不確定性因素持續增加,公司將持續提升海外工廠綜合競爭優勢,並持續關注海外市場,以尋找更多新的發展機遇。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.